Illumina Completes Acquisition of GenoLogics
September 01 2015 - 6:30AM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) today announced it has completed
the acquisition of GenoLogics Life Science Software Inc., a
developer of industry leading laboratory information management
systems (LIMS) for life sciences organizations.
"We look forward to working with the talented team at GenoLogics
and to further integrate their life science software as part of the
overall Illumina informatics solution," said Francis deSouza,
President of Illumina. “Adopted by more than 120 genomic labs
worldwide, GenoLogics’s Clarity LIMS software strengthens our
industry leading portfolio of genetic analysis solutions.”
The completion of the acquisition demonstrates Illumina’s
commitment to drive the adoption of sequencing in new markets and
improve the genomic workflow. GenoLogics’ Clarity LIMS™ software
enables lab efficiencies and improved sample throughput with
increased accuracy, fast turnaround, sample traceability, and
preconfigured instrument integrations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150901005460/en/
Illumina, Inc.Investors:Rebecca Chambers,
858-255-5243rchambers@illumina.comorMedia:Eric Endicott,
858-882-6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024